Correlation between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes

Correlation between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes

Background and objective Pembrolizumab, an immunotherapy for advanced non-small cell lung cancer (NSCLC), needs to predict treatment response based on test results including immunohistochemistry (IHC), which detects the expression of programmed death ligand 1 (PD-L1). The aim of this study was to ev...

Full description

Bibliographic Details
Main Authors: Haiyue MA, Jia JIA, Huiqin GUO, Huan ZHAO, Cong WANG, Linlin ZHAO, Yue SUN, Weihua LI, Zhihui ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2020-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
programmed death ligand 1
immunocytochemistry
lung adenocarcinoma
pleural effusion cell block
next-generation sequencing
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.03

Similar Items